Management board

Uwe Zimdars (CEO)

Uwe Zimdars

Mr. Uwe Zimdars holds a degree in business management and began his career in the Auditing and Management Consulting division of Arthur Andersen. Later, Mr. Zimdars led a large logistics services provider as managing director for several years. His core experiences are in the fields of strategic and operational planning as well as digitalization.    

 

Daniel Kracht (CFO)

Daniel Kracht

Mr. Daniel Kracht, after his studies of business management, has held several posi-tions in tax advisory and commercial planning. Since 2011, Mr. Kracht has been part of HAEMATO's leadership team as Head of Group Accounting and Controlling. Since 1 January 2017, Mr. Kracht is a member of the Management Board of HAEMATO PHARM GmbH.     

 

preview-dummy-image

Die HAEMATO AG ist ein börsennotiertes pharmazeutisches Unternehmen mit Fokus auf die Wachstumsmärkte der hochpreisigen Spezial-Pharmazeutika aus den...

preview-dummy-image

Die HAEMATO AG ist ein börsennotiertes pharmazeutisches Unternehmen mit Fo-kus auf die Wachstumsmärkte patentfreier und patentgeschützter Arzneimittel...

preview-dummy-image

IFRS-Ergebnis Q1 2017, Umsatz 67,9 Mio. Euro (Vorjahresperiode: 67,9 Mio. Euro), EBIT 2,8 Mio. Euro (Vorjahresperiode: 3,5 Mio. Euro)...

Order service - Telephone: +49 30 677 98 67 60
Aktuelle News